Explore more Norwegian companies →

COMPANY CARD COMPANY

PHARMA NORGE AS

Business reg. no. 919 821 590ASØKSNESIndustry code 47.270

Retail sale of other food

Equity ratio: Good · 55,7 % (2025)

View company as shareholder →

Company financial statements in NOK · 2023: 40 477 581 NOK · 2024: 55 161 814 NOK · 2025: 63 089 966 NOK
2023–2025 · NOK
Operating revenue63,1 million NOK
2025 · company↑ 14,4 % from 2024
Company financial statements in NOK · 2023: 8 374 989 NOK · 2024: 15 456 739 NOK · 2025: 7 496 799 NOK
2023–2025 · NOK
Operating income · EBIT7,5 million NOK
2025 · company↓ 51,5 % from 2024

11,9 % EBIT margin

Registered employees23 employees
RegisteredRegistry data 17.11.2026

FINANCIALS

Financial statements and key figures

Amount in whole currency units
Company financial statements

Amount in NOK

Company financial statements · amounts without rounding to thousands for display
Financial statement item202520242023
CurrencyNOKNOKNOK
Operating revenue63 089 96655 161 81440 477 581
Operating profit7 496 79915 456 7398 374 989
Net income8 089 24914 178 9626 784 721
Equity29 269 47835 482 69732 469 334
Total assets52 552 67648 251 12240 405 037
EBIT margin11,9 %28,0 %20,7 %

Indicators: equity / assets and EBIT / operating revenue. Midline is 0%, scale −100% to +100%. Not a credit assessment.

Show trend in NOK
Operating revenueNOK · 2023–202563,1 million NOK
↑ 14,4 % from 2024
Operating revenue202320242025

Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.

Operating profitNOK · 2023–20257,5 million NOK
↓ 51,5 % from 2024
Operating profit202320242025

Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.

Sources and conversion basis

Companies and corporate groups are kept separate. The same historical annual exchange rate is used for income statement and balance sheet figures. Missing values are shown as “—”. Actual zero values are retained.

  • 2025 · NOK · original-NOK · source version 3c096dfdbf72
  • 2024 · NOK · original-NOK · source version 5f5c719f2654
  • 2023 · NOK · original-NOK · source version db03c1eb39f3

Expand for more financial statement items. We show items with information in at least one year. “—” means a value is missing for that year.

Income statement13 entries with information
Company financial statements · Income statement · whole currency units
Financial statement item202520242023
Operating revenue
Total sales revenue61 905 39254 464 48040 186 474
Total operating revenue63 089 96655 161 81440 477 581
Operating expenses
Wage costs8 125 6889 964 9779 580 785
Total operating expenses55 593 16639 705 07532 102 593
Operating profit
Operating income (EBIT)7 496 79915 456 7398 374 989
Financial income
Total finance income1 120 788489 426387 387
Financial expenses
Other interest expense282 404102 50116 065
Total finance costs368 017560 75517 572
Net finance result752 771-71 329369 816
Results and tax
Income before tax8 249 57115 385 4108 744 804
Tax expense on ordinary income160 3221 206 4481 960 083
Net income8 089 24914 178 9626 784 721
Total comprehensive income8 089 24914 178 9626 784 721
Balance sheet13 entries with information
Company financial statements · Balance sheet · whole currency units
Financial statement item202520242023
Financial fixed assets
Total non-current assets37 862 40526 867 82631 283 051
Current assets
Total inventory5 730 6782 160 9231 215 136
Total receivables8 643 90414 718 5016 562 803
Total cash and cash equivalents315 6894 503 8731 344 048
Total current assets14 690 27121 383 2979 121 986
Total assets52 552 67648 251 12240 405 037
Equity
Total paid-in equity23 064 70023 064 70023 069 100
Total retained earnings6 204 77812 417 9979 400 234
Total equity29 269 47835 482 69732 469 334
Provisions and long-term liabilities
Total long-term liabilities—1 206 4480
Current liabilities
Total current liabilities23 283 19811 561 9777 935 703
Total liabilities23 283 19812 768 4257 935 703
Total
Total equity and liabilities52 552 67648 251 12240 405 037
Reported dividends
Amount in NOK
Financial yearDividends – Income statementDividends – Balance sheetData dateAccounting scope
20241 000 000 NOK—26.10.2026Not stated
20233 500 000 NOK—26.10.2026Not stated
20216 100 000 NOK—26.10.2026Not stated
202010 400 000 NOK1 800 000 NOK17.11.2026Company financial statements

Income statement and balance sheet are separate accounting fields and must not be added together. “—” means missing information or an unconfirmed zero. The data date is the export date or the archive completion date.

Source: Brønnøysundregistrene

Executive salary
Company financial statements · NOK
Financial yearReported CEO salary
2020900 000 NOK

Source: Brønnøysundregistrene · Amount in NOK

REGISTRY INFORMATION

Company at a glance

Registered
Industry
47.270 · Retail sale of other food Industry classification: Statistics Norway · CC BY 4.0
Registered address
Sørvåg, 8432 ALSVÅG
Founded
01.10.2017
Entity type
Main entity

ADDRESS AND PROPERTY

Property information

Open data

Sørvåg, 8432 ALSVÅG

Loading property information …

© Kartverket · CC BY 4.0

Companies at the same address

Available company cards

    About the address match

    Same registered street address, postal code, and municipality. This does not document ownership, tenancy, or who uses the building. The address match does not identify a specific unit or dwelling. Open information does not show titleholders, sale date, plot area, or a complete building overview.

    REGISTERED ROLES

    The people and companies behind it.

    Search registered roles →Explore positions and documented connections.
    NameRoleSource date
    Thomas Kristoffer StorvestreBorn 1987Chair of the board16.11.2026
    BOKHOLDERIET ASView role recordAccountant16.11.2026
    REVICOM ASView role recordAuditor16.11.2026
    Rune MeyerBorn 1968General manager16.11.2026
    ØKORÅD ØKSNES ASView role recordAccountant16.11.2026

    Source: Brønnøysund Register Centre. A registered role is not documentation of direct contact information.

    YEAR-DATED OWNERSHIP

    Reported shareholders.

    Search shareholders →Find a shareholder and follow reported ownership entries.

    As of 31 December 2025 · 4 of 4 available ownership entries

    ShareholderShare / share classSource date
    GLOBAL PHARMA GROUP ASView ownership entryView share entries →88,40 % · Ordinary shares31.12.2025
    JAN-PETTER KROGHBorn 1956 · LANDEGODE6,48 % · Ordinary shares31.12.2025
    PHARMA NORGE ASView ownership entryView share entries →3,53 % · Ordinary shares31.12.2025
    INFUTURE INVEST ASView ownership entryView share entries →1,58 % · Ordinary shares31.12.2025
    Distribution of share count 31.12.2025
    100,0 %displayed share of shares
    • GLOBAL PHARMA GROUP ASOrdinary shares88,40 %
    • JAN-PETTER KROGHOrdinary shares6,48 %
    • PHARMA NORGE ASOrdinary shares3,53 %
    • INFUTURE INVEST ASOrdinary shares1,58 %

    Fixed scale 0–100%. Shares are not normalized. Any unfilled portion is outside the displayed total.

    Source: Skatteetaten. Ownership share is a share of the number of shares, not necessarily voting rights or control. Person names refer to separate source records. Similar names are not automatically the same person.

    Previously reported ownership entries (35)

    YEAR-DATED OWNERSHIP

    Company share entries

    The company’s own investments in other businesses. Shareholders who own the company are shown under Ownership.

    Source and scope

    Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.

    Up to 500 source records examined; the view may be limited. Missing matches do not prove that ownership is absent.

    YEAR-DATED OWNERSHIP

    Indirect ownership

    Explore documented ownership paths through companies. Each path and share class is shown separately; shares are not added together.

    Source and scope

    Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.

    Up to four ownership levels, 32 company lookups, and 250 chains are examined within a short time budget. This is a limited selection, not a ranking of the largest 250. Cycles are stopped. Missing matches do not prove that ownership is absent.

    CONNECTIONS

    Explore the ownership structure.

    Directly reported ownership entries are shown first. Open the map to explore further.

    Direct ownership entries without an interactive map

    As of 31 December 2025 · 4 of 4 available ownership entries

    ShareholderShare / share classSource date
    GLOBAL PHARMA GROUP ASView ownership entryView share entries →88,40 % · Ordinary shares31.12.2025
    JAN-PETTER KROGHBorn 1956 · LANDEGODE6,48 % · Ordinary shares31.12.2025
    PHARMA NORGE ASView ownership entryView share entries →3,53 % · Ordinary shares31.12.2025
    INFUTURE INVEST ASView ownership entryView share entries →1,58 % · Ordinary shares31.12.2025

    Source: Skatteetaten / Aksjonærregisteret. Year-dated share ownership is not necessarily today’s voting rights or corporate control.

    Open interactive map for direct ownership entries

    CONNECTIONS

    Explore the ownership structure.

    See owners and open further company levels, using the same year throughout the tree.

    Year-end ownership